(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid, 250mg

2,5-Bis(4-dimethylaminobenzylidene)cyclopentanone, 5g

tert-Butyl 5-methyl-2,4-dioxopiperidine-1-carboxylate, 95.0%, 250mg

(1H-INDAZOL-6-YL)METHANOL, 95%, 100mg

6-(2-METHOXYETHOXY)QUINAZOLIN-4-OL, 95.0%, 250mg

Matraces aforados clase A transparente, 1000 ml, 24/29, 1 Pieza

1-(5-(trifluoromethyl)pyridin-2-yl)pyrrolidin-3-amine, 95.0%, 500mg

9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate, 98%, 25g

tert-Butyl N-{[1-(bromomethyl)cyclopropyl]methyl}carbamate, 98%, 1g

tert-Butyl (3aS,7aS)-octahydro-6H-pyrrolo[2,3-c]pyridine-6-carboxylate, 98%, 100mg

(+)-3-Bromocamphor-8-sulfonic Acid Ammonium Salt>98.0%(T)5g

(S)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione, 98%, 500g

(S)-2-Morpholinopropanoic acid, 98%, 50mg